EP 253: The genetics of brain size, growth, and aging with Andrew Jackson

Value of the Information & Strength of the Argument

The podcast provides valuable insights into the genetic basis of growth and aging, with a strong emphasis on the importance of studying rare diseases. Jackson’s arguments are well-structured, drawing on his extensive research experience and specific examples from his lab’s work. He effectively explains complex concepts like the DNA methylation clock and the role of DNMT3A in a clear and accessible manner. The discussion is balanced, acknowledging uncertainties and the need for further validation, which enhances the credibility of the information presented.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, as Jackson is a leading expert in the field, and the discussion is grounded in his published research. He references specific studies, including those from his own lab, and the show notes provide links to two Nature Genetics papers. The title accurately reflects the content, focusing on the genetics of brain size, growth, and aging. The conversation is well-structured, with clear explanations and a logical flow, though it is an informal podcast rather than a formal scientific review.

The title accurately reflects the core topics discussed: the genetics of brain size, growth, and aging, with a focus on Andrew Jackson's research.

8/10

The discussion is led by a leading researcher in the field, with references to specific published studies. However, it is an informal podcast conversation, and some claims are speculative or based on personal experience rather than systematically reviewed evidence.

• 00:00Intro to The Genetics Podcast
• 00:59Welcome to Andrew
• 01:33The origins of Andrew's work linking brain size and aging
• 03:02The genetics of mammalian size range and epigenetic factors regulating growth
• 05:21How DNMT3A mutations causing dwarfism led to discovering an accelerated aging syndrome
• 10:23Cell number rather than cell size as the shared driver of growth and aging
• 14:12Whether brain size within humans actually predicts cognitive ability
• 16:37Why intellectual disability has far more known genes than dwarfism
• 21:22Discovering ribonuclease H2's role in DNA repair, and its unexpected link to cancer
• 25:58Why studying rare monogenic diseases reveals broader biology
• 29:44Andrew's next research questions on aging, cancer, and mutation biology
• 31:42Why humans, model organisms, and cell assays each have a role
• 34:20Somatic mosaicism's growing role in aging and disease beyond cancer
• 40:20Closing remarks

• Nature Genetics paper on DNMT3A mutations (2018) — Discussed as the original work identifying gain-of-function DNMT3A mutations causing microcephalic dwarfism.
• Nature Genetics paper on DNMT3A and aging (2026) — Referenced as the most recent paper linking DNMT3A mutations to an accelerated aging syndrome.

• Nature Genetics paper on DNMT3A mutations (2018) — The paper is directly cited in the podcast and supports the claims about DNMT3A mutations causing dwarfism.
• Nature Genetics paper on DNMT3A and aging (2026) — The paper is directly cited in the podcast and supports the claims about the accelerated aging syndrome.